NSE shareholding pattern
Alivus Life Sciences Ltd shareholding pattern
As of the Jun 2026 shareholding pattern, filed 2026-06-30, promoters held 74.87%, FIIs 5.54%, and DIIs 7.18% of Alivus Life Sciences Ltd (ALIVUS). Against the Mar 2026 pattern, FII holding is up 0.24 percentage points (5.3% → 5.54%), DII down 0.09 points (7.27% → 7.18%), and promoter holding unchanged at 74.87%. The table below shows how promoter, FII, DII and public holding has moved quarter by quarter, taken from the NSE shareholding pattern.
Definition
A shareholding pattern is the quarterly breakdown of who owns a listed company, split across promoters, foreign institutional investors (FII), domestic institutional investors (DII), and the public. Indian companies file it every quarter under SEBI listing rules. Source: NSE shareholding pattern.
Alivus Life Sciences Ltd shareholding by quarter
| Quarter | Promoter % | FII % | DII % | Public % | Filed |
|---|---|---|---|---|---|
| Jun 2026 | 74.87 | 5.54 | 7.18 | 12.41 | 2026-06-30 |
| Mar 2026 | 74.87 | 5.3 | 7.27 | 12.56 | 2026-03-31 |
| Dec 2025 | 74.91 | 5.08 | 7.13 | 12.88 | 2025-12-31 |
| Sep 2025 | 74.91 | 6.84 | 5.47 | 12.78 | 2025-09-30 |
Disclosures shown are public regulatory filings. Data may be delayed or incomplete. Smart-money entities may no longer hold positions shown. Not investment advice.
Disclosure overlap on Alivus Life Sciences Ltd
3 fund managers3 fund managers disclosed positions in Alivus Life Sciences Ltd within the same window (Apr 19, 2026 – Jul 18, 2026), per AMFI mutual-fund portfolios. Who they are — and each underlying filing — is shown inside Flock.
A count of what was filed, per public regulatory filings. Not investment advice.
Related on Flock
- Smart money moves this filing week (insider trades, bulk deals and stake disclosures from the last 7 days)
- All NSE shareholding patterns (browse every company by name)
- What is a 13F filing? (how the US equivalent disclosure works)
- FII and DII activity, sourced and dated
- Today's NSE and BSE bulk and block deals
- When smart money's filings overlap (multi-entity disclosure overlap, explained)
Frequently asked questions
What is the promoter holding in Alivus Life Sciences Ltd?
As of the Jun 2026 shareholding pattern, promoters held 74.87% of Alivus Life Sciences Ltd (ALIVUS). Figures are taken from the NSE shareholding pattern filing dated 2026-06-30 and may change each quarter. Not investment advice.
What is the FII holding in Alivus Life Sciences Ltd?
Foreign institutional investors held 5.54% of Alivus Life Sciences Ltd as of the Jun 2026 pattern, versus 5.3% in the Mar 2026 pattern. Source: NSE shareholding pattern, filed 2026-06-30. Not investment advice.
How much did FII holding in Alivus Life Sciences Ltd change in the Jun 2026 quarter?
FII holding in Alivus Life Sciences Ltd was 5.3% in the Mar 2026 pattern and 5.54% in Jun 2026, a difference of 0.24 percentage points up. Promoter holding was unchanged at 74.87% across the two filings, and both figures are percentages as filed. Source: NSE shareholding pattern, filed 2026-06-30. Not investment advice.
How often is the shareholding pattern updated?
Listed Indian companies disclose their shareholding pattern every quarter under SEBI's listing rules. Flock re-stamps each page when a new quarterly pattern is filed, so the freshness chip reflects the true age of the latest data.
The Smart Money Digest
A free weekly email of notable disclosure activity — every line with its filing date and source link. No advice, just filings. Unsubscribe anytime.